Mabpharm Limited (HKG:2181)
0.4100
+0.0050 (1.23%)
At close: Mar 6, 2026
24.24% (1Y)
| Market Cap | 1.69B +41.4% |
| Revenue (ttm) | 464.53M +179.6% |
| Net Income | -30.11M |
| EPS | -0.01 |
| Shares Out | 4.12B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,000 |
| Average Volume | 101,900 |
| Open | 0.4100 |
| Previous Close | 0.4050 |
| Day's Range | 0.4100 - 0.4100 |
| 52-Week Range | 0.3500 - 0.9400 |
| Beta | 0.94 |
| RSI | 23.87 |
| Earnings Date | Mar 24, 2026 |